OAC
ICPT

OMERS Administration Corp’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

OMERS Administration Corp’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,900
Closed -$642K – 576
2016
Q3 		$642K Buy
3,900
+600
+18% +$94.6K 0.01% 435
2016
Q2 		$471K Buy
+3,300
New +$481K 0.01% 464

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

OMERS Administration Corp's ICPT Position: Q4 2016 in Review

OMERS Administration Corp sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 3,900 shares — an estimated $642K sold.

OMERS Administration Corp first reported a position in ICPT in Q2 2016 and held it in 2 quarters. The position peaked at $642K in Q3 2016. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • OMERS Administration Corp reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • OMERS Administration Corp sold 3,900 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $642K.
  • OMERS Administration Corp first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2016 and held it in 2 quarters.
  • OMERS Administration Corp's Intercept Pharmaceuticals, Inc. position peaked at $642K in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on OMERS Administration Corp's 13F filing for Q4 2016, filed 9 Feb 2017.